---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020279"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2023-06-06T23:59:59+00:00"
generated_at: "2026-06-14T06:55:59.839357+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech shareholders elect all eight director nominees and ratify auditor at 2023 annual meeting

## Summary
- 7,365,228 shares present at June 1, 2023 meeting; all eight director nominees elected with votes for ranging from 5,512,123 to 5,564,051.
- Ratification of Weaver and Tidwell, L.L.P. as auditor for FY 2023: 6,140,532 for, 0 against.
- Advisory approval of executive compensation: 5,548,532 for, 24,489 against, 888 abstentions.
- All three proposals received sufficient votes to pass.

## SEC filing metadata
- accession: 0001493152-23-020279
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2023-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315223020279/0001493152-23-020279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315223020279/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020279
- JSON: https://secwatch.observer/filing/0001493152-23-020279.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020279.txt

## Key facts
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Election of (i) Ronald T. Nixon, (ii) Robert A. DeSutter, (iii) Roszell Mack III, (iv) Eric D. Major, (v) Sara N. Ortwein, (vi) Ann Beal Salamone, (vii) James W. Stuckert and (viii) Eric D. Tanzberger to the Company’s Board of Directors, each to serve for a one-year term until the annual meeting of at the 2023-06-01 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: Proposal 1 : Election of (i) Ronald T. Nixon, (ii) Robert A. DeSutter, (iii) Roszell Mack III, (iv) Eric D. Major, (v) Sara N. Ortwein, (vi) Ann Beal Salamone, (vii) James W. Stuckert and (viii) Eric D. Tanzberger to the Company’s Board of Directors, each to serve for a one-year term until the annual meeting of shareholders to be held in 2024 or until his or her successor is elected and qualified. Nominee Votes Cast For Votes Withheld Broker Non-Votes Ronald T. Nixon 5,547,819 0 1,817,409 Robert A. DeSutter 5,512,123 60,898 1,792,207 Roszell Mack III 5,556,796 16,225 1,792,207 Eric D. Major 5,556,796 16,225 1,792,207 Sara N. Ortwein 5,556,621 16,400 1,792,207 Ann Beal Salamone 5,555,763 17,258 1,792,207 James W. Stuckert 5,564,051 8,970 1,792,207 Eric D. Tanzberger 5,556,821 16,200 1,792,207
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223020279/0001493152-23-020279-index.htm
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-01 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: Proposal 2 : Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes Cast For Votes Cast Against Abstentions 6,140,532 0 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223020279/0001493152-23-020279-index.htm
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers. at the 2023-06-01 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: Proposal 3 : Approval, on an advisory basis, of the compensation of the Company’s named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 5,548,532 24,489 888 1,791,319
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223020279/0001493152-23-020279-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.